NCT07782658

Brief Summary

Patients admitted to the intensive care unit frequently exhibit abnormal blood bicarbonate levels. These abnormalities are associated with patient outcomes and often prompt clinicians to modify management, either diagnostically or therapeutically (e.g., initiation or adjustment of mechanical ventilation, initiation or modification of extracorporeal renal replacement therapy, administration of specific diuretics, or sodium bicarbonate infusion). Currently, the only way to determine blood bicarbonate concentration is through repeated blood sampling for laboratory analysis. However, this method is both discontinuous and invasive. We have generated an in silico hypothesis suggesting that the mismatch between cellular CO₂ production/elimination and pulmonary CO₂ elimination reflects changes in blood bicarbonate levels. We propose to test this hypothesis in a cohort of intensive care unit patients. If confirmed, indirect calorimetry could be positioned as a continuous, non-invasive monitoring tool for blood bicarbonate.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for all trials

Timeline
12mo left

Started Nov 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 24, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

August 24, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 20, 2026

Last Update Submit

August 20, 2026

Conditions

Keywords

BicarbonateAcid-Base disturbanceIndirect calorimetry

Outcome Measures

Primary Outcomes (1)

  • Correlation coefficient between the CO₂ production/elimination mismatch assessed by indirect calorimetry and the change in blood bicarbonate over the study period.

    CO₂ production/elimination mismatch is estimated using the indirect calorimetry, assuming that the respiratory quotient remains constant throughout the study. Change in blood bicarbonate is obtained using two consecutive arterial blood samples. This relationship will be assessed using Pearson's correlation coefficient if assumptions are met (normality and linearity); otherwise, Spearman's coefficient will be used. The correlation coefficient will be reported with its 95% confidence interval and p-value, and the relationship will be illustrated with a scatter plot and regression line or trend curve.

    At day 1

Study Arms (1)

Study group

Ventilated patient admitted to intensive care unit

Device: Indirect calorimetry measurement

Interventions

Setup of an indirect calorimetry monitor

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the ICU

You may qualify if:

  • Adult patient admitted to the ICU within the past 72 hours
  • Receiving invasive mechanical ventilation
  • For whom the treating clinician plans to perform at least two blood bicarbonate measurements within the next 6 hours
  • No objection from the participant or their next of kin

You may not qualify if:

  • Planned weaning from invasive mechanical ventilation or ventilator change before the second bicarbonate measurement
  • Conditions interfering with the interpretation of indirect calorimetry data:
  • Inspiratory oxygen fraction \> 60%
  • Administration of inhaled medications, including nitric oxide
  • Positive end-expiratory pressure (PEEP) \> 15 cmH₂O
  • Excessive leaks in the ventilator circuit, defined as expired volume \< 95% of inspired volume
  • Patient on mechanical circulatory support with a gas exchanger, or planned initiation before the second blood gas analysis
  • Patient on extracorporeal renal replacement therapy, or planned initiation before the second bicarbonate measurement
  • Frequent disconnections of the ventilator circuit, or planned bronchoscopy before the second bicarbonate measurement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon

Bron, Rhone, 69500, France

Location

Central Study Contacts

Rémi SCHWEIZER, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2026

First Posted

August 24, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

August 24, 2026

Record last verified: 2026-08

Locations